Follow Us On :
About Us
Company Profile
From the Chairman's Desk
Vision, Core Values
Milestones
Board of Directors
Management Profile
Mergers & Acquisitions
International Operations
Strategy
Subsidiaries
Bell, Sons & Co. (Druggists) Ltd.
Nova Pharmaceuticals Australasia Pty Ltd.
Relonchem Limited
Time Cap Labs, Inc.
R & D Capabilities
Quality Policy
World Wide Operations
Formulation Business
Overview
Markets
USA
Europe
South East Asia
Africa
Russia & CIS
Latin America
Australasia
Manufacturing Facilities
Locations (Goa/ Southport - UK)
R & D
CRAMS
Out Licensing
Business Development
Investor Relations
General Information & Investor Contact
General Information
Investor Contact
Corporate Announcements
Financial Results
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Compliances
Shareholding Pattern
Corporate Governance
Codes & Policies
Independent Directors
Investors Grievance Report
Shareholders Meeting
Unclaimed Dividend
CSR Activities
Others Disclosures
Press Release
PD
Industry Overview
Health and Illness
Oncology And Critical Care
The Disorders Of The Mind And Nerves
Neurological Disorder
Mental Disorders
Skin Infections And Ulcers
Gastro - Intestinal Disorders (GI)
Cough Remedies
Women's Health
Bacterial Infections And Its Treatment
Blog
Careers
Overview
Values
Life at Marksans
Contact Us
Open Menu
Home
About Us
Company Profile
From the Chairman's Desk
Vision, Core Values
Milestones
Board of Directors
Management Profile
Mergers & Acquisitions
International Operations
Strategy
Subsidiaries
Bell, Sons & Co. (Druggists) Ltd.
Nova Pharmaceuticals Australasia Pty Ltd.
Relonchem Limited
Time Cap Labs, Inc.
R & D Capabilities
Quality Policy
World Wide Operations
Formulation Business
Overview
Markets
USA
Europe
South East Asia
Africa
Russia & CIS
Latin America
Manufacturing Facilities
Locations (Goa/ Southport - UK)
R & D
CRAMS
Out Licensing
Business Development
Investor Relations
General Information & Investor Contact
General Information
Investor Contact
Corporate Announcements
Financial Results
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Compliances
Shareholding Pattern
Corporate Governance
Codes & Policies
Independent Directors
Investors Grievance Report
Shareholders Meeting
Unclaimed Dividend
CSR Activities
Others Disclosures
Press Release
PD
Industry Overview
Health and Illness
Oncology And Critical Care
The Disorders Of The Mind And Nerves
Neurological Disorder
Mental Disorders
Skin Infections And Ulcers
Gastro - Intestinal Disorders (GI)
Cough Remedies
Women's Health
Bacterial Infections And Its Treatment
Blog
Careers
Overview
Values
Life at Marksans
Contact Us
Site Map
Investor Relations
Financial Results
Annual Reports
Quarterly Reports
Analysts Presentation
Compliances
Shareholding Pattern
PD
Contact Us
Home
Investor Relations
Financial Results
Quarterly Reports
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
September 2005
December 2005
March 2006
June 2006
September 2006
December 2006
March 2007
June 2007
September 2007
December 2007
June 2008
June 2009
September 2009
December 2009
March 2010
March 2011
June 2011
September 2011
March 2012
June 2012
September 2012
December 2012
March 2013
June 2013
September 2013
Standalone Results
Consolidate Results
December 2013
Standalone Results
Consolidate Results
Review Report 2014
December 2014
June 2014
September 2014
March 2015
June 2015
September 2015
December 2015
March 2016
June 2016
September 2016
December 2016
March 2017
June 2017
September 2017
December 2017
March 2018
June 2018
September 2018
December 2018
March 2019
June 2019
September 2019
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
March 2019
June 2019
September 2019
March 2018
June 2018
September 2018
December 2018
March 2017
June 2017
September 2017
December 2017
March 2016
June 2016
September 2016
December 2016
March 2015
June 2015
September 2015
December 2015
Review Report 2014
December 2014
June 2014
September 2014
March 2013
June 2013
September 2013
Standalone Results
Consolidate Results
December 2013
Standalone Results
Consolidate Results
March 2012
June 2012
September 2012
December 2012
March 2011
June 2011
September 2011
March 2010
June 2009
September 2009
December 2009
June 2008
March 2007
June 2007
September 2007
December 2007
March 2006
June 2006
September 2006
December 2006
September 2005
December 2005
© Copyright 2013 Marksans Pharma.